Skip to main content
AMP 2024 Annual Meeting & Expo Main banner
Final Program


Icon Legend
Back

    Karen L. Kaul, MD, PhD (she/her/hers)

    Chair, Department of Pathology and Laboratory Medicine
    NorthShore Hospitals / Endeavor Health
    Evanston, Illinois, United States

    Karen Kaul MD, PhD

    Dr. Karen Kaul is Chair of the Department of Pathology and Laboratory Medicine at NorthShore and is a Clinical Professor of Pathology at the University of Chicago’s Pritzker School of Medicine. Dr. Kaul is board-certified in Anatomic Pathology, and Molecular Genetic Pathology. Following a postdoctoral fellowship at the NCI and pathology residency training at Northwestern, Dr. Kaul established one of the earliest Molecular Diagnostics laboratories in the US; she and her lab have been deeply involved in the development of laboratory tests for cancer, heritable conditions, microbial diseases, and antimicrobial susceptibility. She has been significantly involved in education, regulation, and standardization of the practice of molecular pathology, and has served on FDA, CLIAC, MEDCAC, and other panels, and testified before the Senate HELP committee on LDPs in 2016. She is a past president of the Association for Molecular Pathology, and served as Editor in Chief of the Journal of Molecular Diagnostics until 2010. She is the recipient of the 2008 Association for Molecular Pathology Leadership Award. She was an ELAM (Executive Leadership in Academic Medicine) fellow in 2011-2012. From 2011-2023, she was a Trustee of the American Board of Pathology where she was involved in professional examination and certification efforts, and is a past President of the ABP. She also served on the ACGME Residency Review Committee for Pathology, and Milestones committees, and chaired the Association for Pathology Chairs GME committee. Dr. Kaul served as residency program director for 18 years, and served on PRODS council before becoming departmental chair in 2012. As Chair, she has led departmental efforts to improve laboratory efficiency and utilization, and maximize the impact of the laboratory on clinical care. She continues to practice and advocate for Molecular Pathology.


    Presentation(s):